Ok let’s get right to the point as we only have short time between presentations and this is BIG news – as promised we asked Abbott about the status of the Libre2, specifically when would it get here and will it get an iCGM designation. Remember last week at CES Abbott representatives were telling attendees that Libre2 would not be here for another year, which if accurate would be a major blow to Abbott.
Well according to Abbott CEO Robert Ford they have submitted more data and information to the FDA and are confident they will gain iCGM.
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.